PL1979474T3 - Ptasia odwrotna transkryptaza o charakterze telomerazy - Google Patents

Ptasia odwrotna transkryptaza o charakterze telomerazy

Info

Publication number
PL1979474T3
PL1979474T3 PL07703676T PL07703676T PL1979474T3 PL 1979474 T3 PL1979474 T3 PL 1979474T3 PL 07703676 T PL07703676 T PL 07703676T PL 07703676 T PL07703676 T PL 07703676T PL 1979474 T3 PL1979474 T3 PL 1979474T3
Authority
PL
Poland
Prior art keywords
telomerase reverse
reverse transcriptase
avian
cells
nucleic acid
Prior art date
Application number
PL07703676T
Other languages
English (en)
Inventor
Philippe Erbs
Jean-Marc Balloul
Marina Kapfer
Nathalie Silvestre
Original Assignee
Transgene Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transgene Sa filed Critical Transgene Sa
Publication of PL1979474T3 publication Critical patent/PL1979474T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/12Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241Nucleotidyltransferases (2.7.7)
    • C12N9/1276RNA-directed DNA polymerase (2.7.7.49), i.e. reverse transcriptase or telomerase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/12Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL07703676T 2006-01-05 2007-01-05 Ptasia odwrotna transkryptaza o charakterze telomerazy PL1979474T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP06360001 2006-01-05
EP06360047 2006-10-13
PCT/EP2007/050120 WO2007077256A1 (en) 2006-01-05 2007-01-05 Avian telomerase reverse transcriptase
EP07703676A EP1979474B1 (en) 2006-01-05 2007-01-05 Avian telomerase reverse transcriptase

Publications (1)

Publication Number Publication Date
PL1979474T3 true PL1979474T3 (pl) 2011-01-31

Family

ID=38016619

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07703676T PL1979474T3 (pl) 2006-01-05 2007-01-05 Ptasia odwrotna transkryptaza o charakterze telomerazy

Country Status (20)

Country Link
US (1) US9024003B2 (pl)
EP (1) EP1979474B1 (pl)
JP (2) JP5661243B2 (pl)
KR (1) KR101337377B1 (pl)
CN (1) CN102268413A (pl)
AT (1) ATE477321T1 (pl)
AU (1) AU2007204024B2 (pl)
BR (1) BRPI0706836B1 (pl)
CA (1) CA2636329C (pl)
CY (1) CY1110860T1 (pl)
DE (1) DE602007008360D1 (pl)
DK (1) DK1979474T3 (pl)
HK (1) HK1122069A1 (pl)
HR (1) HRP20100484T1 (pl)
PL (1) PL1979474T3 (pl)
PT (1) PT1979474E (pl)
RS (1) RS51525B (pl)
RU (1) RU2415867C2 (pl)
SI (1) SI1979474T1 (pl)
WO (1) WO2007077256A1 (pl)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101337377B1 (ko) * 2006-01-05 2013-12-09 트랜스진 에스.에이. 조류 텔로머라아제 역전사효소
EP1985305A1 (en) * 2007-04-24 2008-10-29 Vivalis Duck embryonic derived stem cell lines for the production of viral vaccines
US8357531B2 (en) * 2007-07-03 2013-01-22 Transgene S.A. Immortalized avian cell lines
KR101014030B1 (ko) 2008-08-29 2011-02-14 현대자동차주식회사 와이어링 취부용 플랜지 및 제조공정
AU2010247374A1 (en) * 2009-05-12 2011-12-15 Transgene Sa Immortalized avian cell lines and use thereof
US20120309056A1 (en) 2010-02-04 2012-12-06 Leon Arnaud Fed-batch process using concentrated cell culture medium for the efficient production of biologics in eb66 cells
WO2012095514A1 (en) 2011-01-14 2012-07-19 Vivalis Recombinant protein production system
EP2724157B1 (en) 2011-06-27 2017-03-08 Valneva Method for screening cells
TW201318637A (zh) 2011-09-29 2013-05-16 Transgene Sa 免疫療法組成物及用於治療c型肝炎病毒感染之療程(一)
TW201321016A (zh) 2011-09-29 2013-06-01 Transgene Sa 免疫療法組成物及用於治療c型肝炎病毒感染之療程(二)
MX2017007178A (es) 2014-12-01 2017-08-28 Transgene Sa Formulaciones liquidas estables de virus de vacuna.
CN107002044B (zh) 2014-12-04 2020-10-30 英特维特国际股份有限公司 永生化鸡胚成纤维细胞
WO2017191147A1 (en) 2016-05-04 2017-11-09 Transgene Sa Combination therapy with cpg tlr9 ligand
US20190328869A1 (en) 2016-10-10 2019-10-31 Transgene Sa Immunotherapeutic product and mdsc modulator combination therapy
CN110769850A (zh) 2017-05-15 2020-02-07 扬森疫苗与预防公司 稳定的含病毒组合物
US11306292B2 (en) 2017-05-15 2022-04-19 Janssen Vaccines & Prevention B.V. Stable virus-containing composition
KR102684237B1 (ko) 2017-06-21 2024-07-11 트랜스진 개인 맞춤형 백신
EP3638777A4 (en) * 2017-07-13 2021-05-12 Memphis Meats, Inc. COMPOSITIONS AND METHODS FOR INCREASING THE EFFICIENCY OF CELL CULTURES FOR FOOD MANUFACTURING
CA3111273C (en) 2018-09-06 2024-03-26 Bavarian Nordic A/S Storage improved poxvirus compositions
FR3089789B1 (fr) 2018-12-14 2022-05-27 Univ Claude Bernard Lyon Production de vaccins viraux sur une lignee cellulaire aviaire
EP3842065A1 (en) 2019-12-23 2021-06-30 Transgene Process for designing a recombinant poxvirus for a therapeutic vaccine
MX2022011071A (es) 2020-03-12 2022-09-23 Bavarian Nordic As Composiciones que mejoran la estabilidad del poxvirus.
JP2023533584A (ja) 2020-07-13 2023-08-03 トランジェーヌ 免疫低下の処置
WO2023213763A1 (en) 2022-05-02 2023-11-09 Transgene Poxvirus encoding a binding agent comprising an anti- pd-l1 sdab
WO2023213764A1 (en) 2022-05-02 2023-11-09 Transgene Fusion polypeptide comprising an anti-pd-l1 sdab and a member of the tnfsf

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002300900A (ja) 2001-04-05 2002-10-15 National Institute Of Advanced Industrial & Technology 腫瘍悪性化因子および腫瘍悪性化を抑制する化合物のスクリーニング方法
JPWO2003038076A1 (ja) 2001-10-31 2005-02-24 株式会社レノメディクス研究所 不死化間葉系細胞及びその利用
JP3897717B2 (ja) * 2002-04-23 2007-03-28 オリンパス株式会社 細胞移植治療材料およびその製造方法
KR101337377B1 (ko) * 2006-01-05 2013-12-09 트랜스진 에스.에이. 조류 텔로머라아제 역전사효소

Also Published As

Publication number Publication date
ATE477321T1 (de) 2010-08-15
KR101337377B1 (ko) 2013-12-09
JP5661243B2 (ja) 2015-01-28
DE602007008360D1 (de) 2010-09-23
WO2007077256B1 (en) 2007-10-25
US20100173378A1 (en) 2010-07-08
AU2007204024A1 (en) 2007-07-12
CA2636329A1 (en) 2007-07-12
BRPI0706836B1 (pt) 2021-05-25
RS51525B (en) 2011-06-30
RU2415867C2 (ru) 2011-04-10
EP1979474A1 (en) 2008-10-15
HRP20100484T1 (hr) 2010-10-31
EP1979474B1 (en) 2010-08-11
WO2007077256A1 (en) 2007-07-12
RU2008125815A (ru) 2010-02-10
JP2013027397A (ja) 2013-02-07
CY1110860T1 (el) 2015-06-10
JP2009521945A (ja) 2009-06-11
HK1122069A1 (en) 2009-05-08
AU2007204024B2 (en) 2012-01-19
KR20080085074A (ko) 2008-09-22
SI1979474T1 (sl) 2010-10-29
US9024003B2 (en) 2015-05-05
CN102268413A (zh) 2011-12-07
DK1979474T3 (da) 2010-09-20
PT1979474E (pt) 2010-10-22
BRPI0706836A2 (pt) 2011-04-05
CA2636329C (en) 2016-12-13

Similar Documents

Publication Publication Date Title
HK1122069A1 (en) Avian telomerase reverse transcriptase
WO2015112767A3 (en) Novel reverse transcriptases for use in high temperature nucleic acid synthesis
MX2014007233A (es) Composiciones de nucleosidos, nucleotidos y acidos nucleicos modificados.
WO2011106766A3 (en) Modified proteins and methods of making and using same
DE602006018709D1 (de) Estergebundene geminitensidverbindungen zur verwendung in der gentherapie
MX2010001490A (es) Acidos nucleicos de enlace sdf-1 y uso de los mismos.
EA200970580A1 (ru) Таннат разагилина
WO2014028429A3 (en) Enzymes and polymerases for the synthesis of rna
ATE502122T1 (de) Chemisch modifizierte oligonukleotidprimer zur nukleinsäureamplifikation
EA201171220A1 (ru) Мутанты fgf21 и их применение
MX2017009767A (es) Nuevas proteínas específicas para la angiogénesis.
EA201690946A1 (ru) Мутанты fgf21 и их применение
TW200800968A (en) Sulfoximine-substituted pyrimidines, processes for production thereof and use thereof as drugs
WO2009120374A3 (en) Methods and compositions for nucleic acid sample preparation
WO2010041913A3 (ko) Grs 단백질 또는 이의 단편의 신규한 용도
WO2009039189A3 (en) Compositions comprising stat3 sirna and methods of use thereof
EA200870514A1 (ru) Ацетиленовые гетероарильные соединения
WO2014197805A3 (en) Molecular barcoding for multiplex sequencing
EA200970472A1 (ru) Замещенные пиразолы, композиции, их содержащие, способ получения и применение
WO2007045019A3 (en) Polyoleosins
WO2009047634A3 (en) Aqueous formulations of acetaminophen for injection
ATE542915T1 (de) Cst-ii-modifzierungen für erhöhte proteinexpression
WO2009081283A3 (en) Aqueous formulations of acetaminophen for injection
WO2009143281A3 (en) Compositions comprising c-met sirna and methods of use thereof
WO2009143277A3 (en) Compositions comprising hscn9a sirna and methods of use thereof